GenScript Biotech Corporation (HKEX: 1548), a global company providing life science research services and products, biologics development & manufacturing services, and industrial biotechnology ...

Genscript Biotech Corp (GNNSF) reports a 61.4% revenue surge to $959.5 million, driven by strategic global expansion and key partnerships.

LONDON, Nov. 21, 2024 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the European debut of its GenScript Biotech ...

SAN FRANCISCO--(BUSINESS WIRE)--Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corporation ...

Legend Biotech has managed to remove GenScript Biotech as its majority shareholder, just as the former parent’s Chinese background falls under a U.S. biosecurity microscope. After a financial maneuver ...

GenScript announced the official opening of its first European mRNA production site in Delft, the Netherlands, marking a significant ...

Genscript Biotech ( (HK:1548)) just unveiled an update. Genscript Biotech Corporation announced the financial results for the third quarter of 2025 for its associate, Legend Biotech Corporation, which ...

Panel discussions brought to life important insights into how AI could change the face of biopharma drug discovery in 2026 and beyond PISCATAWAY, N.J., Jan. 29, 2026 /PRNewswire/ -- GenScript Biotech ...

Analysts expect annual sales of Carvykti, Legend Biotech’s core cancer therapy, to peak at $7.3 billion With about $2 billion in cash reserves, Genscript isn’t under pressure to sell its 48% holding ...